Description
Teneliximab (BMS-224819) is a chimeric monoclonal antibody, blocks the CD40-CD40L interaction. Teneliximab (BMS-224819) has partial agonist activity resulting in some signaling through CD40 and peripheral B cell depletion.
Cat.No
A992
Name
Teneliximab
Chemical Properties
CAS
299423-37-3
Synonyms
Immunoglobulin G1,anti-(human CD40 (antigen)) (human-mouse monoclonal chi220 g1-chain), disulfide withhuman-mouse monoclonal chi220 light chain, dimer (9CI);Immunoglobulin G1,anti-(human CD40 (antigen)) (human-mouse monoclonal chi220 g1-chain), disulfide withhuman-mouse monoclonal ;BMS224819;Teneliximab;Anti-cd40 mab;Bms-224819;Research Grade Teneliximab (DHD68909);Chi220|||Anti-Human CD40 Recombinant Antibody|||BMS 224819;Chi220|||Anti-Human CD40 Recombinant Antibody|||BMS 224819;Chi220|||Anti-Human CD40 Recombinant Antibody|||BMS 224819;Chi220|||Anti-Human CD40 Recombinant Antibody|||BMS 224819;Chi220|||Anti-Human CD40 Recombinant Antibody|||BMS 224819;Chi220|||Anti-Human CD40 Recombinant Antibody|||BMS 224819;Chi220|||Anti-Human CD40 Recombinant Antibody|||BMS 224819
pH value
Corresponds to reference standard: PASS
Non-reduced CE-SDS
>95%
SEC-HPLC
>95%
Isoelectric Point
Corresponds to reference standard
Bacterial Endotoxins Test
Residual Proteins of Host Cell
Exogenous Residual DNA
Residual protein A
Biological Activity
Osmolality
Corresponds to reference standard: PASS
Peptide mapping
Corresponds to reference standard: PASS
N-terminal sequence
Corresponds to reference standard: PASS
References
Return Policy
If you are in any way unsatisfied with your purchase, you may return any item(s) within 365 days of its original purchase date.
Please provide your Order Number in the email. We strive to reply to all email inquiries within one business day.
Tel: +86-21-58447131Fax: +86-21-61642470Email:
Website:
